Danicopan structure
|
Common Name | Danicopan | ||
|---|---|---|---|---|
| CAS Number | 1903768-17-1 | Molecular Weight | 580.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H23BrFN7O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DanicopanDanicopan, a selective and orally active small-molecule factor D inhibitor, inhibits alternative pathway of complement (APC) activity. Danicopan has potential to block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)[1]. |
| Name | Danicopan |
|---|
| Description | Danicopan, a selective and orally active small-molecule factor D inhibitor, inhibits alternative pathway of complement (APC) activity. Danicopan has potential to block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)[1]. |
|---|---|
| Related Catalog | |
| Target |
Factor D[1] |
| References |
| Molecular Formula | C26H23BrFN7O3 |
|---|---|
| Molecular Weight | 580.41 |
| InChIKey | PIBARDGJJAGJAJ-NQIIRXRSSA-N |
| SMILES | CC(=O)c1nn(CC(=O)N2CC(F)CC2C(=O)Nc2cccc(Br)n2)c2ccc(-c3cnc(C)nc3)cc12 |